IN2012DN03818A - - Google Patents

Download PDF

Info

Publication number
IN2012DN03818A
IN2012DN03818A IN3818DEN2012A IN2012DN03818A IN 2012DN03818 A IN2012DN03818 A IN 2012DN03818A IN 3818DEN2012 A IN3818DEN2012 A IN 3818DEN2012A IN 2012DN03818 A IN2012DN03818 A IN 2012DN03818A
Authority
IN
India
Application number
Other languages
English (en)
Inventor
Irene Erdelmeier
Original Assignee
Tetrahedron
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tetrahedron filed Critical Tetrahedron
Publication of IN2012DN03818A publication Critical patent/IN2012DN03818A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/84Sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B55/00Racemisation; Complete or partial inversion
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
IN3818DEN2012 2009-10-06 2012-05-01 IN2012DN03818A (enExample)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0956962A FR2950889B1 (fr) 2009-10-06 2009-10-06 Procede de synthese de l'ergothioneine et analogues
PCT/EP2010/064950 WO2011042480A1 (fr) 2009-10-06 2010-10-06 Procede de synthese de l'ergothioneine et analogues

Publications (1)

Publication Number Publication Date
IN2012DN03818A true IN2012DN03818A (enExample) 2015-08-28

Family

ID=41650166

Family Applications (1)

Application Number Title Priority Date Filing Date
IN3818DEN2012 IN2012DN03818A (enExample) 2009-10-06 2012-05-01

Country Status (13)

Country Link
US (1) US8399500B2 (enExample)
EP (1) EP2486020B1 (enExample)
JP (2) JP5813647B2 (enExample)
KR (1) KR101832396B1 (enExample)
CN (1) CN102686568B (enExample)
AU (1) AU2010305399B2 (enExample)
BR (1) BR112012007869B1 (enExample)
CA (1) CA2776836C (enExample)
ES (1) ES2646331T3 (enExample)
FR (1) FR2950889B1 (enExample)
IN (1) IN2012DN03818A (enExample)
RU (1) RU2550202C2 (enExample)
WO (1) WO2011042480A1 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2950890B1 (fr) 2009-10-06 2011-12-30 Tetrahedron Procede de synthese de la 2-thiohistidine et analogues
KR102116734B1 (ko) * 2012-12-21 2020-05-29 핑후아 리오우 대사 공학을 통한 에르고티오네인 생성
US10544437B2 (en) 2014-04-29 2020-01-28 Conagen Inc. Microbial ergothioneine biosynthesis
FR3021655B1 (fr) 2014-05-30 2016-07-08 Tetrahedron Nouveaux composes de type 5-acylsulfanyl-histidine en tant que precurseurs des 5-sulfanylhistidines correspondantes et de leurs disulfures
GB201416678D0 (en) * 2014-09-22 2014-11-05 Univ Cape Town Process For Synthesizing Ergothioneine And Its Intermediates
CN107848984B (zh) * 2015-03-13 2021-08-24 米洛诺瓦创新有限责任公司 用于制备麦角硫因化合物的Nα,Nα,Nα-三烷基组氨酸衍生物
BR112022000183A2 (pt) 2019-07-10 2022-02-22 Kureha Corp Regulador de crescimento de plantal e método para promover o crescimento de planta
JP6864131B1 (ja) * 2020-03-04 2021-04-28 長瀬産業株式会社 L−エルゴチオネイン含有組成物
KR20220081067A (ko) 2020-12-08 2022-06-15 코오롱인더스트리 주식회사 에르고티오네인 생산능이 향상된 재조합 효모 및 이를 이용한 에르고티오네인의 생산 방법
WO2023004608A1 (en) * 2021-07-28 2023-02-02 Nanjing Nutrabuilding Bio-Tech Co., Ltd. L-ergothioneine and therapeutic uses thereof
US11491141B1 (en) 2022-01-06 2022-11-08 Nanjing Nutrabuilding Bio-Tech Co., Ltd. Methods of treating glutathione deficiencies and deficiencies in glutathione synthetase activity
CN119032084A (zh) * 2022-04-22 2024-11-26 南京纽邦生物科技有限公司 麦角硫因的化学合成方法和使用方法
WO2024009937A1 (ja) 2022-07-06 2024-01-11 株式会社クレハ 植物生長調整剤、植物の生長促進方法または植物生長調整用製品
AR130564A1 (es) 2022-09-27 2024-12-18 Kureha Corp Agente para mejorar la tolerancia al estrés ambiental en una planta y método para mejorar la tolerancia al estrés ambiental en una planta
CN116102502A (zh) * 2022-11-28 2023-05-12 南京艾希帝生物科技有限公司 一种麦角硫因的合成方法
WO2025143153A1 (ja) * 2023-12-27 2025-07-03 株式会社クレハ 植物の生育期間短縮化剤および生育期間短縮用の製剤、花成誘導遺伝子の発現誘導剤、植物の生育期間を短縮化させる方法、植物体、植物の生育速度の均一化剤、ならびに植物の生育速度を均一化させる方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2707087B1 (fr) * 1993-06-28 1995-10-13 Bioxytech Nouveau procédé de préparation de l'ergothionéine.
GB9811427D0 (en) * 1998-05-29 1998-07-22 Zeneca Ltd Chemical compounds
AU2005289998A1 (en) * 2004-09-24 2006-04-06 Allergan, Inc. 4-(condensed cyclicmethyl)-imidazole-2-thiones acting as alpha2 adrenergic agonists
US7115748B2 (en) * 2004-12-07 2006-10-03 Allergan, Inc. Method of making imidazole-2-thiones
US7767826B2 (en) * 2007-10-05 2010-08-03 Pharmatech International, Inc. Process for the synthesis of L-(+)-ergothioneine
JP2009161498A (ja) * 2008-01-10 2009-07-23 Univ Nagoya エルゴチオネインの製造方法

Also Published As

Publication number Publication date
CN102686568A (zh) 2012-09-19
RU2550202C2 (ru) 2015-05-10
JP2016006099A (ja) 2016-01-14
US20120136159A1 (en) 2012-05-31
CA2776836A1 (fr) 2011-04-14
AU2010305399A1 (en) 2012-05-17
KR20120091187A (ko) 2012-08-17
KR101832396B1 (ko) 2018-02-26
CN102686568B (zh) 2015-03-18
EP2486020B1 (fr) 2017-08-16
AU2010305399B2 (en) 2014-06-12
FR2950889A1 (fr) 2011-04-08
JP2013506706A (ja) 2013-02-28
JP5813647B2 (ja) 2015-11-17
BR112012007869A2 (pt) 2015-09-22
ES2646331T3 (es) 2017-12-13
EP2486020A1 (fr) 2012-08-15
RU2012117978A (ru) 2013-11-20
US8399500B2 (en) 2013-03-19
FR2950889B1 (fr) 2011-11-18
WO2011042480A1 (fr) 2011-04-14
BR112012007869B1 (pt) 2021-10-13
CA2776836C (fr) 2019-01-15

Similar Documents

Publication Publication Date Title
BE2015C040I2 (enExample)
BRPI0925311A2 (enExample)
BR112012008195A2 (enExample)
BR112012003062A2 (enExample)
BRPI0924307A2 (enExample)
BR112012008267A2 (enExample)
BR112012000607A2 (enExample)
BR122021004633A2 (enExample)
BR112012000665A2 (enExample)
BR112012003080A2 (enExample)
BR112012012487A2 (enExample)
BR122017024704A2 (enExample)
BR112012003853A2 (enExample)
BR112012009797A2 (enExample)
BR112012012080A2 (enExample)
BR112012009446A2 (enExample)
BR112012009703A2 (enExample)
BRPI0924534A2 (enExample)
BR112012010357A2 (enExample)
BR112012007656A2 (enExample)
BR112012001263A2 (enExample)
BR122019005883A2 (enExample)
BR112012014856A2 (enExample)
BR112012000159A2 (enExample)
BRPI1004942A2 (enExample)